TRIMEPRAZINE TARTRATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Trimeprazine Tartrate, and what generic alternatives are available?
Trimeprazine Tartrate is a drug marketed by Alpharma Us Pharms and Morton Grove and is included in two NDAs.
The generic ingredient in TRIMEPRAZINE TARTRATE is trimeprazine tartrate. There are five drug master file entries for this compound. Additional details are available on the trimeprazine tartrate profile page.
Summary for TRIMEPRAZINE TARTRATE
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 1 |
Patent Applications: | 123 |
Formulation / Manufacturing: | see details |
DailyMed Link: | TRIMEPRAZINE TARTRATE at DailyMed |
Medical Subject Heading (MeSH) Categories for TRIMEPRAZINE TARTRATE
US Patents and Regulatory Information for TRIMEPRAZINE TARTRATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Alpharma Us Pharms | TRIMEPRAZINE TARTRATE | trimeprazine tartrate | SYRUP;ORAL | 085015-001 | Feb 18, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Morton Grove | TRIMEPRAZINE TARTRATE | trimeprazine tartrate | SYRUP;ORAL | 088285-001 | Apr 11, 1985 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |